HEADER HYDROLASE/INHIBITOR 08-NOV-24 9KGQ TITLE DISCOVERY OF AN ORALLY BIOAVAILABLE REVERSIBLE COVALENT SARS-COV-2 TITLE 2 MPRO INHIBITOR WITH PAN-CORONAVIRUS ACTIVITY COMPND MOL_ID: 1; COMPND 2 MOLECULE: 3C-LIKE PROTEINASE NSP5; COMPND 3 CHAIN: B, A; COMPND 4 SYNONYM: 3CL-PRO,3CLP,MAIN PROTEASE,MPRO,NON-STRUCTURAL PROTEIN 5, COMPND 5 NSP5,SARS CORONAVIRUS MAIN PROTEINASE; COMPND 6 EC: 3.4.22.69; COMPND 7 ENGINEERED: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: COMPOUND 4; COMPND 10 CHAIN: C, D; COMPND 11 SYNONYM: (S)-2-((R)-2-ACETAMIDO-3-METHYLBUTANAMIDO)-4-METHYL-N-((S)- COMPND 12 1-OXO-3-((S)-2-OXOPYRROLIDIN-3-YL)PROPAN-2-YL)PENTANAMIDE; COMPND 13 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS SOURCE 3 2; SOURCE 4 ORGANISM_TAXID: 2697049; SOURCE 5 GENE: REP, 1A-1B; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 SYNTHETIC: YES; SOURCE 10 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 11 ORGANISM_TAXID: 32630 KEYWDS PROTEASE, COV2, HYDROLASE, HYDROLASE-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR N.BABURAJENDRAN REVDAT 2 10-SEP-25 9KGQ 1 JRNL REVDAT 1 20-AUG-25 9KGQ 0 JRNL AUTH Q.W.TAN,S.VANKADARA,J.Y.FONG,Y.Y.SEE,N.BABURAJENDRAN,P.S.NG, JRNL AUTH 2 W.XU,Y.K.YEO,W.WANG,C.H.LOW,L.H.TAN,E.G.JU TAY,Y.X.WONG, JRNL AUTH 3 C.HUANG,S.SIM,S.H.ANG,H.H.MIN TOH,J.MOHAMMAD,G.WANG,B.LIU, JRNL AUTH 4 S.T.TAN,P.Z.KWEK,M.D.DAWSON,Q.Y.OH,X.KOH,J.JOY,M.A.LEE, JRNL AUTH 5 W.STUNKEL,V.PENDHARKAR,H.HENTZE,S.P.LIM,K.ETHIRAJULU, JRNL AUTH 6 C.S.BRIAN CHIA,J.CHERIAN JRNL TITL DISCOVERY OF AN ORALLY BIOAVAILABLE REVERSIBLE COVALENT JRNL TITL 2 SARS-COV-2 M PRO INHIBITOR WITH PAN-CORONAVIRUS ACTIVITY. JRNL REF J.MED.CHEM. V. 68 17087 2025 JRNL REFN ISSN 0022-2623 JRNL PMID 40773370 JRNL DOI 10.1021/ACS.JMEDCHEM.5C00581 REMARK 2 REMARK 2 RESOLUTION. 1.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.14_3260 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 46.57 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.0 REMARK 3 NUMBER OF REFLECTIONS : 97080 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.201 REMARK 3 R VALUE (WORKING SET) : 0.200 REMARK 3 FREE R VALUE : 0.233 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 2.070 REMARK 3 FREE R VALUE TEST SET COUNT : 2008 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 46.5700 - 3.6100 0.97 6802 147 0.1539 0.1620 REMARK 3 2 3.6100 - 2.8600 0.98 6834 142 0.1888 0.2525 REMARK 3 3 2.8600 - 2.5000 0.99 6861 144 0.2094 0.2333 REMARK 3 4 2.5000 - 2.2700 0.99 6891 150 0.2137 0.2732 REMARK 3 5 2.2700 - 2.1100 0.99 6826 137 0.2107 0.2556 REMARK 3 6 2.1100 - 1.9900 0.99 6823 152 0.2185 0.2522 REMARK 3 7 1.9900 - 1.8900 0.99 6868 139 0.2158 0.2405 REMARK 3 8 1.8900 - 1.8000 0.99 6784 145 0.2183 0.2617 REMARK 3 9 1.8000 - 1.7300 0.99 6829 158 0.2349 0.3042 REMARK 3 10 1.7300 - 1.6700 0.98 6802 129 0.2523 0.2529 REMARK 3 11 1.6700 - 1.6200 0.98 6741 143 0.2830 0.3120 REMARK 3 12 1.6200 - 1.5800 0.98 6804 148 0.3102 0.3361 REMARK 3 13 1.5800 - 1.5300 0.98 6727 147 0.3390 0.3889 REMARK 3 14 1.5300 - 1.5000 0.94 6480 127 0.3714 0.3928 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.231 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 28.714 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 23.80 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 32.46 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.012 4746 REMARK 3 ANGLE : 1.238 6454 REMARK 3 CHIRALITY : 0.102 734 REMARK 3 PLANARITY : 0.009 836 REMARK 3 DIHEDRAL : 10.018 1664 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 9KGQ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 11-NOV-24. REMARK 100 THE DEPOSITION ID IS D_1300053568. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 16-OCT-20 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : AUSTRALIAN SYNCHROTRON REMARK 200 BEAMLINE : MX2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.95365 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 97141 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.500 REMARK 200 RESOLUTION RANGE LOW (A) : 46.570 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.2 REMARK 200 DATA REDUNDANCY : 3.500 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 8.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.52 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 6Y2G REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.01 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.28 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 4% V/V TACSIMATETM PH 6.0, 12% W/V REMARK 280 POLYETHYLENE GLYCOL 3,350, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 49.64700 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3990 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 25470 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -22.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, A, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY B -4 REMARK 465 PRO B -3 REMARK 465 LEU B -2 REMARK 465 GLY B -1 REMARK 465 SER B 0 REMARK 465 VAL B 303 REMARK 465 THR B 304 REMARK 465 PHE B 305 REMARK 465 GLN B 306 REMARK 465 GLY A -4 REMARK 465 PRO A -3 REMARK 465 LEU A -2 REMARK 465 GLY A -1 REMARK 465 SER A 0 REMARK 465 SER A 1 REMARK 465 GLY A 2 REMARK 465 GLN A 299 REMARK 465 CYS A 300 REMARK 465 SER A 301 REMARK 465 GLY A 302 REMARK 465 VAL A 303 REMARK 465 THR A 304 REMARK 465 PHE A 305 REMARK 465 GLN A 306 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU B 47 CG CD OE1 OE2 REMARK 470 ASP B 48 CG OD1 OD2 REMARK 470 LYS B 137 CG CD CE NZ REMARK 470 ASP B 153 CG OD1 OD2 REMARK 470 ARG B 222 CG CD NE CZ NH1 NH2 REMARK 470 TYR A 154 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 ASP A 155 CG OD1 OD2 REMARK 470 ARG A 188 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 222 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 298 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 CYS B 22 CB CYS B 22 SG -0.170 REMARK 500 CYS B 44 CB CYS B 44 SG -0.154 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LYS A 5 CD - CE - NZ ANGL. DEV. = 16.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP B 33 -127.41 54.12 REMARK 500 ASN B 51 76.96 -151.83 REMARK 500 ASN B 84 -123.00 55.24 REMARK 500 ASP B 155 19.22 54.80 REMARK 500 SER B 284 138.02 -171.68 REMARK 500 ARG A 4 -179.63 -171.02 REMARK 500 ASP A 33 -124.52 54.10 REMARK 500 ASN A 51 80.73 -165.76 REMARK 500 ASN A 84 -122.24 51.88 REMARK 500 PRO A 184 40.20 -86.86 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 531 DISTANCE = 5.91 ANGSTROMS DBREF 9KGQ B 1 306 UNP P0DTD1 R1AB_SARS2 3264 3569 DBREF 9KGQ A 1 306 UNP P0DTD1 R1AB_SARS2 3264 3569 DBREF 9KGQ C 1 4 PDB 9KGQ 9KGQ 1 4 DBREF 9KGQ D 1 4 PDB 9KGQ 9KGQ 1 4 SEQADV 9KGQ GLY B -4 UNP P0DTD1 EXPRESSION TAG SEQADV 9KGQ PRO B -3 UNP P0DTD1 EXPRESSION TAG SEQADV 9KGQ LEU B -2 UNP P0DTD1 EXPRESSION TAG SEQADV 9KGQ GLY B -1 UNP P0DTD1 EXPRESSION TAG SEQADV 9KGQ SER B 0 UNP P0DTD1 EXPRESSION TAG SEQADV 9KGQ GLY A -4 UNP P0DTD1 EXPRESSION TAG SEQADV 9KGQ PRO A -3 UNP P0DTD1 EXPRESSION TAG SEQADV 9KGQ LEU A -2 UNP P0DTD1 EXPRESSION TAG SEQADV 9KGQ GLY A -1 UNP P0DTD1 EXPRESSION TAG SEQADV 9KGQ SER A 0 UNP P0DTD1 EXPRESSION TAG SEQRES 1 B 311 GLY PRO LEU GLY SER SER GLY PHE ARG LYS MET ALA PHE SEQRES 2 B 311 PRO SER GLY LYS VAL GLU GLY CYS MET VAL GLN VAL THR SEQRES 3 B 311 CYS GLY THR THR THR LEU ASN GLY LEU TRP LEU ASP ASP SEQRES 4 B 311 VAL VAL TYR CYS PRO ARG HIS VAL ILE CYS THR SER GLU SEQRES 5 B 311 ASP MET LEU ASN PRO ASN TYR GLU ASP LEU LEU ILE ARG SEQRES 6 B 311 LYS SER ASN HIS ASN PHE LEU VAL GLN ALA GLY ASN VAL SEQRES 7 B 311 GLN LEU ARG VAL ILE GLY HIS SER MET GLN ASN CYS VAL SEQRES 8 B 311 LEU LYS LEU LYS VAL ASP THR ALA ASN PRO LYS THR PRO SEQRES 9 B 311 LYS TYR LYS PHE VAL ARG ILE GLN PRO GLY GLN THR PHE SEQRES 10 B 311 SER VAL LEU ALA CYS TYR ASN GLY SER PRO SER GLY VAL SEQRES 11 B 311 TYR GLN CYS ALA MET ARG PRO ASN PHE THR ILE LYS GLY SEQRES 12 B 311 SER PHE LEU ASN GLY SER CYS GLY SER VAL GLY PHE ASN SEQRES 13 B 311 ILE ASP TYR ASP CYS VAL SER PHE CYS TYR MET HIS HIS SEQRES 14 B 311 MET GLU LEU PRO THR GLY VAL HIS ALA GLY THR ASP LEU SEQRES 15 B 311 GLU GLY ASN PHE TYR GLY PRO PHE VAL ASP ARG GLN THR SEQRES 16 B 311 ALA GLN ALA ALA GLY THR ASP THR THR ILE THR VAL ASN SEQRES 17 B 311 VAL LEU ALA TRP LEU TYR ALA ALA VAL ILE ASN GLY ASP SEQRES 18 B 311 ARG TRP PHE LEU ASN ARG PHE THR THR THR LEU ASN ASP SEQRES 19 B 311 PHE ASN LEU VAL ALA MET LYS TYR ASN TYR GLU PRO LEU SEQRES 20 B 311 THR GLN ASP HIS VAL ASP ILE LEU GLY PRO LEU SER ALA SEQRES 21 B 311 GLN THR GLY ILE ALA VAL LEU ASP MET CYS ALA SER LEU SEQRES 22 B 311 LYS GLU LEU LEU GLN ASN GLY MET ASN GLY ARG THR ILE SEQRES 23 B 311 LEU GLY SER ALA LEU LEU GLU ASP GLU PHE THR PRO PHE SEQRES 24 B 311 ASP VAL VAL ARG GLN CYS SER GLY VAL THR PHE GLN SEQRES 1 A 311 GLY PRO LEU GLY SER SER GLY PHE ARG LYS MET ALA PHE SEQRES 2 A 311 PRO SER GLY LYS VAL GLU GLY CYS MET VAL GLN VAL THR SEQRES 3 A 311 CYS GLY THR THR THR LEU ASN GLY LEU TRP LEU ASP ASP SEQRES 4 A 311 VAL VAL TYR CYS PRO ARG HIS VAL ILE CYS THR SER GLU SEQRES 5 A 311 ASP MET LEU ASN PRO ASN TYR GLU ASP LEU LEU ILE ARG SEQRES 6 A 311 LYS SER ASN HIS ASN PHE LEU VAL GLN ALA GLY ASN VAL SEQRES 7 A 311 GLN LEU ARG VAL ILE GLY HIS SER MET GLN ASN CYS VAL SEQRES 8 A 311 LEU LYS LEU LYS VAL ASP THR ALA ASN PRO LYS THR PRO SEQRES 9 A 311 LYS TYR LYS PHE VAL ARG ILE GLN PRO GLY GLN THR PHE SEQRES 10 A 311 SER VAL LEU ALA CYS TYR ASN GLY SER PRO SER GLY VAL SEQRES 11 A 311 TYR GLN CYS ALA MET ARG PRO ASN PHE THR ILE LYS GLY SEQRES 12 A 311 SER PHE LEU ASN GLY SER CYS GLY SER VAL GLY PHE ASN SEQRES 13 A 311 ILE ASP TYR ASP CYS VAL SER PHE CYS TYR MET HIS HIS SEQRES 14 A 311 MET GLU LEU PRO THR GLY VAL HIS ALA GLY THR ASP LEU SEQRES 15 A 311 GLU GLY ASN PHE TYR GLY PRO PHE VAL ASP ARG GLN THR SEQRES 16 A 311 ALA GLN ALA ALA GLY THR ASP THR THR ILE THR VAL ASN SEQRES 17 A 311 VAL LEU ALA TRP LEU TYR ALA ALA VAL ILE ASN GLY ASP SEQRES 18 A 311 ARG TRP PHE LEU ASN ARG PHE THR THR THR LEU ASN ASP SEQRES 19 A 311 PHE ASN LEU VAL ALA MET LYS TYR ASN TYR GLU PRO LEU SEQRES 20 A 311 THR GLN ASP HIS VAL ASP ILE LEU GLY PRO LEU SER ALA SEQRES 21 A 311 GLN THR GLY ILE ALA VAL LEU ASP MET CYS ALA SER LEU SEQRES 22 A 311 LYS GLU LEU LEU GLN ASN GLY MET ASN GLY ARG THR ILE SEQRES 23 A 311 LEU GLY SER ALA LEU LEU GLU ASP GLU PHE THR PRO PHE SEQRES 24 A 311 ASP VAL VAL ARG GLN CYS SER GLY VAL THR PHE GLN SEQRES 1 C 4 ACE DVA LEU ELL SEQRES 1 D 4 ACE DVA LEU ELL HET ACE C 1 3 HET DVA C 2 7 HET ELL C 4 11 HET ACE D 1 3 HET DVA D 2 7 HET ELL D 4 11 HETNAM ACE ACETYL GROUP HETNAM DVA D-VALINE HETNAM ELL (2S)-2-AZANYL-3-[(3S)-2-OXIDANYLIDENEPYRROLIDIN-3- HETNAM 2 ELL YL]PROPANAL FORMUL 3 ACE 2(C2 H4 O) FORMUL 3 DVA 2(C5 H11 N O2) FORMUL 3 ELL 2(C7 H12 N2 O2) FORMUL 5 HOH *326(H2 O) HELIX 1 AA1 SER B 10 GLY B 15 1 6 HELIX 2 AA2 HIS B 41 CYS B 44 5 4 HELIX 3 AA3 ASN B 53 ARG B 60 1 8 HELIX 4 AA4 SER B 62 PHE B 66 5 5 HELIX 5 AA5 ILE B 200 ASN B 214 1 15 HELIX 6 AA6 THR B 226 TYR B 237 1 12 HELIX 7 AA7 THR B 243 LEU B 250 1 8 HELIX 8 AA8 LEU B 250 GLY B 258 1 9 HELIX 9 AA9 ALA B 260 GLY B 275 1 16 HELIX 10 AB1 THR B 292 SER B 301 1 10 HELIX 11 AB2 SER A 10 GLY A 15 1 6 HELIX 12 AB3 HIS A 41 CYS A 44 5 4 HELIX 13 AB4 GLU A 47 ASN A 51 5 5 HELIX 14 AB5 ASN A 53 ARG A 60 1 8 HELIX 15 AB6 SER A 62 PHE A 66 5 5 HELIX 16 AB7 ILE A 200 ASN A 214 1 15 HELIX 17 AB8 THR A 226 TYR A 237 1 12 HELIX 18 AB9 THR A 243 LEU A 250 1 8 HELIX 19 AC1 LEU A 250 THR A 257 1 8 HELIX 20 AC2 ALA A 260 GLY A 275 1 16 HELIX 21 AC3 THR A 292 ARG A 298 1 7 SHEET 1 AA1 7 VAL B 73 LEU B 75 0 SHEET 2 AA1 7 LEU B 67 ALA B 70 -1 N VAL B 68 O LEU B 75 SHEET 3 AA1 7 MET B 17 CYS B 22 -1 N THR B 21 O LEU B 67 SHEET 4 AA1 7 THR B 25 LEU B 32 -1 O LEU B 27 N VAL B 20 SHEET 5 AA1 7 VAL B 35 PRO B 39 -1 O TYR B 37 N LEU B 30 SHEET 6 AA1 7 VAL B 86 VAL B 91 -1 O LEU B 87 N CYS B 38 SHEET 7 AA1 7 VAL B 77 GLN B 83 -1 N GLN B 83 O VAL B 86 SHEET 1 AA2 3 LYS B 100 PHE B 103 0 SHEET 2 AA2 3 CYS B 156 GLU B 166 1 O PHE B 159 N LYS B 102 SHEET 3 AA2 3 HIS B 172 THR B 175 -1 O ALA B 173 N MET B 165 SHEET 1 AA3 5 SER B 121 ALA B 129 0 SHEET 2 AA3 5 THR B 111 TYR B 118 -1 N ALA B 116 O SER B 123 SHEET 3 AA3 5 VAL B 148 ASP B 153 -1 O PHE B 150 N SER B 113 SHEET 4 AA3 5 CYS B 156 GLU B 166 -1 O SER B 158 N ASN B 151 SHEET 5 AA3 5 DVA C 2 LEU C 3 -1 O DVA C 2 N GLU B 166 SHEET 1 AA4 7 VAL A 73 LEU A 75 0 SHEET 2 AA4 7 LEU A 67 ALA A 70 -1 N ALA A 70 O VAL A 73 SHEET 3 AA4 7 MET A 17 CYS A 22 -1 N GLN A 19 O GLN A 69 SHEET 4 AA4 7 THR A 25 LEU A 32 -1 O LEU A 27 N VAL A 20 SHEET 5 AA4 7 VAL A 35 PRO A 39 -1 O TYR A 37 N LEU A 30 SHEET 6 AA4 7 VAL A 86 VAL A 91 -1 O LEU A 87 N CYS A 38 SHEET 7 AA4 7 VAL A 77 GLN A 83 -1 N GLN A 83 O VAL A 86 SHEET 1 AA5 3 LYS A 100 PHE A 103 0 SHEET 2 AA5 3 CYS A 156 GLU A 166 1 O PHE A 159 N LYS A 102 SHEET 3 AA5 3 HIS A 172 THR A 175 -1 O ALA A 173 N MET A 165 SHEET 1 AA6 5 SER A 121 ALA A 129 0 SHEET 2 AA6 5 THR A 111 TYR A 118 -1 N ALA A 116 O SER A 123 SHEET 3 AA6 5 VAL A 148 ASP A 153 -1 O PHE A 150 N SER A 113 SHEET 4 AA6 5 CYS A 156 GLU A 166 -1 O SER A 158 N ASN A 151 SHEET 5 AA6 5 DVA D 2 LEU D 3 -1 O DVA D 2 N GLU A 166 LINK SG CYS B 145 C ELL C 4 1555 1555 1.78 LINK SG CYS A 145 C ELL D 4 1555 1555 1.78 LINK C ACE C 1 N DVA C 2 1555 1555 1.44 LINK C DVA C 2 N LEU C 3 1555 1555 1.45 LINK C LEU C 3 N ELL C 4 1555 1555 1.45 LINK C ACE D 1 N DVA D 2 1555 1555 1.46 LINK C DVA D 2 N LEU D 3 1555 1555 1.42 LINK C LEU D 3 N ELL D 4 1555 1555 1.45 CRYST1 55.660 99.294 59.927 90.00 108.66 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017966 0.000000 0.006066 0.00000 SCALE2 0.000000 0.010071 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017612 0.00000 CONECT 1109 4613 CONECT 3424 4643 CONECT 4586 4587 4588 4589 CONECT 4587 4586 CONECT 4588 4586 CONECT 4589 4586 4590 CONECT 4590 4589 4591 4594 CONECT 4591 4590 4592 4593 CONECT 4592 4591 CONECT 4593 4591 CONECT 4594 4590 4595 4596 CONECT 4595 4594 CONECT 4596 4594 CONECT 4598 4612 CONECT 4604 4605 CONECT 4605 4604 4606 4609 CONECT 4606 4605 4607 CONECT 4607 4606 4608 CONECT 4608 4607 4609 CONECT 4609 4605 4608 4610 CONECT 4610 4609 4611 CONECT 4611 4610 4612 4613 CONECT 4612 4598 4611 CONECT 4613 1109 4611 4614 CONECT 4614 4613 CONECT 4616 4617 4618 4619 CONECT 4617 4616 CONECT 4618 4616 CONECT 4619 4616 4620 CONECT 4620 4619 4621 4624 CONECT 4621 4620 4622 4623 CONECT 4622 4621 CONECT 4623 4621 CONECT 4624 4620 4625 4626 CONECT 4625 4624 CONECT 4626 4624 CONECT 4628 4642 CONECT 4634 4635 CONECT 4635 4634 4636 4639 CONECT 4636 4635 4637 CONECT 4637 4636 4638 CONECT 4638 4637 4639 CONECT 4639 4635 4638 4640 CONECT 4640 4639 4641 CONECT 4641 4640 4642 4643 CONECT 4642 4628 4641 CONECT 4643 3424 4641 4644 CONECT 4644 4643 MASTER 324 0 6 21 30 0 0 6 4967 4 48 50 END